# CHOLESTYRAMINE

NDC: 70771-1105
Generic name: CHOLESTYRAMINE
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20180801

FDA application: ANDA202901

## Active ingredients

- CHOLESTYRAMINE: 4 g/9g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1105"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1105
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a86715e3-741f-47c6-9682-1413f0f8ff0c